Seeking Alpha

AstraZeneca (AZN -0.1%) will appoint a new CEO over the next six months and the person should be...

AstraZeneca (AZN -0.1%) will appoint a new CEO over the next six months and the person should be aggressive on acquisitions, according to Leerink Swann. Leerink views Forest Labs (FRX +3.5%), a stock it upgraded this morning to Outperform, as the most logical takeover target for AZN, but also feels the company has several other options, including Amylin (AMLN -2.7%) and Salix (SLXP -0.1%).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector